We observed significantly decreased differential expression of SOD3 in individuals with NAFLD, using 3 independent tests comparing individuals with steatosis, fibrosis, and NASH to those with healthy livers. Here, SOD3 is linked to metabolic dysfunction-associated steatohepatitis.